Post by KOELIS

The publication of the VIOLETTE study in BJU International (BJUI and BJUI Compass journals) marks an important milestone, both for the teams involved and in its clinical evaluation. This prospective, multicentre European phase II study evaluated targeted microwave ablation (TMA) guided by OBT Fusion® via KOELIS Trinity® in the treatment of localised intermediate-risk prostate cancer. Conducted across 6 centres and involving 76 treated patients, this publication reflects a rigorous collaborative effort driven by clinical teams committed to advancing the evaluation of focal therapies. Many thanks to Prof. Nicolas Barry Delongchamps, principal investigator, as well as to all co-authors and investigators involved in this study: Hôpital Cochin – Prof. Nicolas Barry Delongchamps, Dr julien anract Institut Jules Bordet – Prof. Alexandre Peltier, Romain Diamand, Prof Roland van Velthoven Clinique Urologique Nantes Atlantis – Dr Eric Potiron CHU de Bordeaux Pellegrin – Prof. Franck Bladou, Prof. Grégoire Robert American Hospital of Paris – Dr Aurel Messas Clinique Saint-Augustin – Dr Jean-Baptiste ROCHE, Dr jean-luc Hoepffner, Dr Thierry Piechaud We would also like to thank the patients who agreed to participate in this study. Study results will be shared in more detail in upcoming posts. Access the full original article in comment. #ProstateCancer #Urology #FocalTherapy #ClinicalResearch #BJUInternational #VIOLETTE